GS-9219/VDC-1101 - a prodrug of the acyclic nucleotide PMEG has antitumor activity inspontaneous canine multiple myeloma

por Thamm, Douglas H, Vail, David M, Kurzman, Ilene D, Babusis, Darius, Ray, Adrian S, Sousa-Powers, Noel, Tumas, Daniel B
Publicado 2014

Pilot study of safety and feasibility of DNA microseeding for treatment of spontaneous canine melanoma

por Zuleger, Cindy L., Kang, Chulhi, Ranheim, Erik A., Kurzman, Ilene D., Macklin, Michael D., Newton, Michael A., Wolchok, Jedd D., Vail, David M., Eriksson, Elof, Albertini, Mark R.
Publicado 2017

Comparative Gene Expression Profiling Identifies Common Molecular Signatures of NF-κB Activation in Canine and Human Diffuse Large B Cell Lymphoma (DLBCL)

por Mudaliar, Manikhandan A. V., Haggart, Ross D., Miele, Gino, Sellar, Grant, Tan, Karen A. L., Goodlad, John R., Milne, Elspeth, Vail, David M., Kurzman, Ilene, Crowther, Daniel, Argyle, David J.
Publicado 2013

Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative (companion dog) setting

por Magee, Kara, Marsh, Ian R., Turek, Michelle M., Grudzinski, Joseph, Aluicio-Sarduy, Eduardo, Engle, Jonathan W., Kurzman, Ilene D., Zuleger, Cindy L., Oseid, Elizabeth A., Jaskowiak, Christine, Albertini, Mark R., Esbona, Karla, Bednarz, Bryan, Sondel, Paul M., Weichert, Jamey P., Morris, Zachary S., Hernandez, Reinier, Vail, David M.
Publicado 2021